Home / Inspections / 1091668

FDA Inspection 1091668 — Janssen Pharmaceuticals, dba Actelion Pharmaceutical

Janssen Pharmaceuticals, dba Actelion Pharmaceutical — FEI 3003498827

The FDA completed an inspection of Janssen Pharmaceuticals, dba Actelion Pharmaceutical on February 28, 2019 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 988929 (VAI Wed Sep 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 873005 (VAI Wed Feb 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 735438 (VAI Thu Jul 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 599116 (OAI Mon Jul 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources